EAM Investors, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 138 filers reported holding SAGE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.55 and the average weighting 0.3%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$2,935,000
-10.4%
18,221
-8.4%
0.49%
-16.7%
Q4 2017$3,277,000
+103.4%
19,896
-47.7%
0.59%
+130.2%
Q3 2015$1,611,000
-64.6%
38,074
-38.9%
0.26%
-52.1%
Q2 2015$4,549,00062,3130.53%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders